The American Society of Clinical Oncology (ASCO) has developed a summary of updates from states and private payers in response to COVID-19. The summary includes information on coverage for laboratory tests, provider visits, telehealth, and other related care, along with changes to prior authorization requirements, network restrictions, and prescription refills, among other updates. This resource is meant to serve as a brief overview for ASCO members to help respond to questions from patients or staff. All oncology care providers are encouraged to consult their state authorities and specific payers for more detailed guidance.
ASCO will continue to monitor developments and will update this summary as needed.
View the summary document.
See more of ASCO's resources related to COVID-19.